SEC Filing Details
Document Details
Form
Filing Date
Apr 7, 2020
Document Date
Apr 3, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
Svennilson Peter
Contact Information
Investor Relations:
ir@ngmbio.com
Media Relations:
media@ngmbio.com
Toolkit